These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response. Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV Front Immunol; 2020; 11():1748. PubMed ID: 32849623 [TBL] [Abstract][Full Text] [Related]
5. Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies. Market M; Angka L; Martel AB; Bastin D; Olanubi O; Tennakoon G; Boucher DM; Ng J; Ardolino M; Auer RC Front Immunol; 2020; 11():1512. PubMed ID: 32655581 [TBL] [Abstract][Full Text] [Related]
6. Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms. Gupta R; Gant VA; Williams B; Enver T Int J Infect Dis; 2020 Oct; 99():381-385. PubMed ID: 32771640 [TBL] [Abstract][Full Text] [Related]
7. Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation. Yang D; Chu H; Hou Y; Chai Y; Shuai H; Lee AC; Zhang X; Wang Y; Hu B; Huang X; Yuen TT; Cai JP; Zhou J; Yuan S; Zhang AJ; Chan JF; Yuen KY J Infect Dis; 2020 Aug; 222(5):734-745. PubMed ID: 32563187 [TBL] [Abstract][Full Text] [Related]
8. Could "trained immunity" be induced by live attenuated vaccines protect against COVID-19? Review of available evidence. Alsulaiman JW; Khasawneh AI; Kheirallah KA J Infect Dev Ctries; 2020 Sep; 14(9):957-962. PubMed ID: 33031080 [TBL] [Abstract][Full Text] [Related]
9. Natural Killer Cell Dysfunction and Its Role in COVID-19. van Eeden C; Khan L; Osman MS; Cohen Tervaert JW Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32883007 [TBL] [Abstract][Full Text] [Related]
10. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm. Nowill AE; de Campos-Lima PO J Immunol; 2020 Nov; 205(10):2566-2575. PubMed ID: 32958687 [TBL] [Abstract][Full Text] [Related]
11. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). Chang FY; Chen HC; Chen PJ; Ho MS; Hsieh SL; Lin JC; Liu FT; Sytwu HK J Biomed Sci; 2020 Jun; 27(1):72. PubMed ID: 32498686 [TBL] [Abstract][Full Text] [Related]
12. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects. Charoenlap S; Piromsopa K; Charoenlap C Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943 [TBL] [Abstract][Full Text] [Related]
13. Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases. Shelly A; Gupta P; Ahuja R; Srichandan S; Meena J; Majumdar T Viruses; 2020 Oct; 12(10):. PubMed ID: 33050511 [TBL] [Abstract][Full Text] [Related]
14. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777 [TBL] [Abstract][Full Text] [Related]
15. Could the Induction of Trained Immunity by β-Glucan Serve as a Defense Against COVID-19? Geller A; Yan J Front Immunol; 2020; 11():1782. PubMed ID: 32760409 [TBL] [Abstract][Full Text] [Related]
16. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports"). Persad G; Emanuel EJ JAMA; 2020 Jun; 323(22):2241-2242. PubMed ID: 32374357 [No Abstract] [Full Text] [Related]